Direct‐Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait‐List Progression or Posttransplant Recurrence
Journal
Liver Transplantation
ISSN
1527-6465
1527-6473
Date Issued
2020
Author(s)
Federico Piñero
Ilka Boin
Aline Chagas
Emilio Quiñonez
Sebastián Marciano
Mario Vilatobá
Luisa Santos
Margarita Anders
Sergio Hoyos Duque
Agnaldo Soares Lima
Josemaría Menendez
Martín Padilla
Jaime Poniachik
Martín Maraschio
Ricardo Chong Menéndez
Linda Muñoz
Diego Arufe
Rodrigo Figueroa
Manuel Mendizabal
Sahara Hurtado Gomez
Raquel Stucchi
Claudia Maccali
Rodrigo Vergara Sandoval
Carla Bermudez
Lucas McCormack
Adriana Varón
Adrián Gadano
Juan Mattera
Fernando Rubinstein
Flair Carrilho
Marcelo Silva
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Subjects
antiviral agents
;
carcinoma, hepatocellular
;
hepatitis c, chronic
;
humans
;
liver neoplasms
;
liver transplantation
;
neoplasm recurrence, local
;
retrospective studies
;
alpha fetoprotein
;
daclatasvir
;
dasabuvir
;
ombitasvir
;
paritaprevir
;
ritonavir
;
sofosbuvir
;
antivirus agent
;
adult
;
article
;
cancer diagnosis
;
cancer risk
;
cancer survival
;
cohort analysis
;
controlled study
;
decompensated liver cirrhosis
;
female
;
hepatitis b
;
hepatitis c
;
hepatitis c virus
;
hospital admission
;
human
;
liver cell carcinoma
;
liver transplantation
;
major clinical study
;
male
;
middle aged
;
multicenter study
;
practice guideline
;
priority journal
;
propensity score
;
recurrent disease
;
response evaluation criteria in solid tumors
;
retrospective study
;
single blind procedure
;
south and central america
;
tumor differentiation
;
tumor growth
;
tumor invasion
;
tumor volume
;
virus load
;
adverse event
;
chronic hepatitis c
;
clinical trial
;
complication
;
liver cell carcinoma
;
liver tumor
;
tumor recurrence